Clinical Case of Castleman’s Disease Located at the Mesorectum

A B S T R A C T

Introduction: A rare benign lymphoid proliferative disorder called Castleman’s disease is the most commonly presented as a solitary mass in the mediastinum, although sometimes with sites at the neck, axilla, mesentery, pancreas, pelvis and retroperitoneum. We report a case of Castleman’s disease in the mesorectum. According to the literature, such localization was visualized just in few cases all over the world.
Case History: The patient was a 48-year-old man, who complained of lumbar pain. MRI was performed in 2014 on which the formation in the presacral mass of mesorectal fat (size up to 4,9*5,2*4,0 cm) on the level of S2 vertebrae was found, which is considered as a lymph node with the tendency to increase during 3, 5 years (+1cm). Upon admission to the clinic, differential diagnosis with lymphoma and malignant tumor were carried out. According to the colonoscopy, there were no evidence about any malignancies in the bowel. After laparoscopic removing of the mesorectal tumor and histological examination of the specimen immunohistochemistry assay was recommended. Following the analysis, the hyaline-vascular type of Castleman's disease was confirmed. Chemotherapy wasn’t recommended, because of radical surgical treatment. According to the results of monitoring in two years, no data of recurrence were identified.
Conclusion: Castleman’s disease should be taken into consideration in the differential diagnosis of lymphoid formations in mesorectum.

Keywords

Case report, Castleman’s disease, lymph nodes, mesorectum, surgery

Get access to the full version of this article.

Article Info

Article Type

Publication history

Copyright

Author Info

Yuliia S. Medkova Dodusov Veniamin Viktorovich Yury E. Kitsenko Sergey K. Efetov Inna A. Tulina Petr V. Tsarkov

Corresponding Author

Figures & Tables

Get access to the full version of this article.

References

1.     Munshi N, Mehra M, van de Velde H, Desai A, Potluri R et al. (2015) Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leuk Lymphoma 56: 1252-1260. [Crossref]

2.     Gonzalez Garcıa A, Moreno Cobo MA, Patier de la Pena JL (2016) Current diagnosis and treatment of Castleman’s disease. Rev Clin Esp 216: 146-156. [Crossref]

3.     Hata T, Ikeda M, Ikenaga M, Yasui M, Shingai T et al. (2007) Castleman’s disease of the rectum: report of a case. Dis Colon Rectum 50: 389-394. [Crossref]

4.     Lee IJ, Kim SC, Kim HS, Bang D, Yang WI et al. (1999) Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman’s tumor. J Am Acad Dermatol 40: 294-297. [Crossref]

5.     Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA et al. (2001) Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97: 2130-2136. [Crossref]

6.     Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD et al. (1999) The management of unicentric and multicentric Castleman’s disease: a report of 16 cases and a review of the literature. Cancer 85: 706-717. [Crossref]

7.     Frizzera G (1988) Castleman’s disease and related disorders. Semin Diagn Pathol 5: 346-364. [Crossref]

8.     Uhlig BE, Johnson RL (1975) Presacral tumors and cysts in adults. Dis Colon Rectum 18: 581-589. [Crossref]

9.     Stewart RJ, Humphreys WG, Parks TG (1986) The presentation and management of presacral tumours. Br J Surg 73: 153-155. [Crossref]

10.  Lowenthal DA, Filippa DA, Richardson ME, Bertoni M, Straus DJ (1987) Generalized lymphadenopathy with morphologic features of Castleman’s disease in an HIV-positive man. Cancer 60: 2454-2458. [Crossref]